Novartis AG
SIX:NOVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVN
|
CH |
|
Jacquet Metals SA
PAR:JCQ
|
FR |
|
B
|
Baidu Inc
OTC:BAIDF
|
CN |
|
10X Genomics Inc
LSE:0A88
|
US |
|
EVRAZ plc
LSE:EVR
|
UK |
|
Tilray Brands Inc
NASDAQ:TLRY
|
US |
|
G
|
Grenergy Renovables SA
XBER:5GR
|
ES |
|
S
|
Sekisui House Ltd
SWB:SPH1
|
JP |
|
D
|
Dai-Dan Co Ltd
TSE:1980
|
JP |
|
Apcotex Industries Ltd
NSE:APCOTEXIND
|
IN |
|
U
|
Under Armour Inc
XBER:U9R
|
US |
|
iQIYI Inc
NASDAQ:IQ
|
CN |
|
A
|
Archies Ltd
NSE:ARCHIES
|
IN |
|
Tenet Healthcare Corp
NYSE:THC
|
US |
|
Arthur J Gallagher & Co
NYSE:AJG
|
US |
|
Tokio Marine Holdings Inc
OTC:TKOMF
|
JP |
|
M
|
Marathon Oil Corp
BMV:MRO
|
US |
|
Yamada Holdings Co Ltd
TSE:9831
|
JP |
|
Element79 Gold Corp
F:7YS0
|
CA |
Wall St Price Targets
NOVN Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOVN is 126.68 CHF with a low forecast of 95.95 CHF and a high forecast of 150.69 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVN's stock price target?
Price Target
126.68
CHF
According to Wall Street analysts, the average 1-year price target for NOVN is 126.68 CHF with a low forecast of 95.95 CHF and a high forecast of 150.69 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 12%.
